original ) (raw )Maximal Cytoreduction in Patients With FIGO Stage IIIC to Stage IV Ovarian, Fallopian, and Peritoneal Cancer in Day-to-Day Practice
Eberhard Stoeckle
International Journal of Gynecological Cancer, 2012
View PDFchevron_right
Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: Results of a gynecologic oncology group study
Howard Homesley
International Journal of Radiation Oncology*Biology*Physics, 1996
View PDFchevron_right
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Antonio Casado
New England Journal of Medicine, 2010
View PDFchevron_right
Prognostic Factors in Patients Undergoing Primary Cytoreductive Surgery for FIGO Stage IIIC Ovarian, Tubal or Peritoneal Cancer
Samet Topuz
Journal of Obstetrics and Gynaecology Canada, 2018
View PDFchevron_right
Management of endometrial cancer
Georgios Androutsopoulos
Int J Translation Community Dis, 2013
View PDFchevron_right
Present and future in endometrial cancer treatment
Georgios Androutsopoulos
Obstet Gynecol Int J, 2015
View PDFchevron_right
Current treatment options in patients with endometrial cancer
Georgios Androutsopoulos
J Community Med Health Educ, 2012
View PDFchevron_right
Surgical Staging and Treatment of Early Ovarian Cancer: Long-term Analysis From a Randomized Trial
Sergio Pecorelli
JNCI Journal of the National Cancer Institute, 2010
View PDFchevron_right
Surgical Stage I Endometrial Cancer: Predictors of Distant Failure and Death
Karl Podratz
Gynecologic Oncology, 2002
View PDFchevron_right
Neoadjuvant Chemotherapy versus Primary Surgery in the Management of Advanced Stage Ovarian Cancer
Azza Zulfu
2015
View PDFchevron_right
Surgical and systemic management of endometrial cancer: an international survey
David S Miller
Archives of Gynecology and Obstetrics, 2014
View PDFchevron_right
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
Sean Kehoe
The Lancet, 2015
View PDFchevron_right
High-risk surgical stage 1 endometrial cancer: analysis of treatment outcome
joao victor
Radiation Oncology, 2006
View PDFchevron_right
Neoadjuvant chemotherapy versus primary surgery for advanced-stage ovarian cancer: the question remains opened
Ahmed Setit
Gynecologic Oncology, 2004
View PDFchevron_right
Surgical Treatment in Ovarian Cancer - Complete or Optimal Surgery?
Lata Warad
ARS Medica Tomitana, 2018
View PDFchevron_right
The Role of Aggressive Surgery in Advanced Epithelial Ovarian Cancer
Jim Julian
Journal SOGC, 2001
View PDFchevron_right
A multi-institutional analysis of sequential versus ‘sandwich’ adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma
Güler Yavas
Journal of Gynecologic Oncology, 2019
View PDFchevron_right
The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma
Curt Burger
BJOG: An International Journal of Obstetrics & Gynaecology, 2009
View PDFchevron_right
A call for prospective studies in early-stage ovarian cancer
Jonathan Ledermann
BJOG: An International Journal of Obstetrics & Gynaecology, 2010
View PDFchevron_right
The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: A gynecologic oncology group study
Robert Ozols , Michael Stany
Gynecologic Oncology, 2011
View PDFchevron_right
New insights in endometrial cancer treatment
Georgios Androutsopoulos
Clinics in Oncology - Endometrial Cancer, 2016
View PDFchevron_right
Effect of grade on disease-free survival and overall survival in FIGO stage I adenocarcinoma of the endometrium
Philippe Coucke
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2000
View PDFchevron_right
Outcome of patients with advanced ovarian cancer who do not undergo debulking surgery: A single institution retrospective review
Adeola Olaitan
Gynecologic Oncology, 2017
View PDFchevron_right
A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study
Howard Homesley
Gynecologic Oncology, 2009
View PDFchevron_right
Assessment of Prognostic Factors in Epithelial Ovarian Cancer-
hilmi kodaz
View PDFchevron_right
Treatment Failure in Endometrial Carcinoma
Chyong-huey Lai
International Journal of Gynecological Cancer, 2014
View PDFchevron_right
Advanced stage ovarian cancer — Does complex surgery improve survival? An analysis of GOG 182
Austin Miller
Gynecologic Oncology, 2012
View PDFchevron_right
Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma
Ahmed Setit
World Journal of Surgical Oncology, 2005
View PDFchevron_right
What is new in endometrial cancer treatment?
Georgios Androutsopoulos
Achaiki Iatriki, 2021
View PDFchevron_right
Neo-adjuvant Chemotherapy Followed by Interval Debulking Surgery Versus Upfront Surgery Followed by Chemotherapy in Advanced Epithelial Ovarian Carcinoma
Mahmoud Meleis
Indian Journal of Gynecologic Oncology, 2016
View PDFchevron_right
Outcomes Following Salvage Radiation Therapy for Recurrent Endometrial Cancer in Patients with No Prior Adjuvant Therapy -- An Institutional Review
Jayson Field
International Journal of Radiation Oncology*Biology*Physics, 2018
View PDFchevron_right